Work

Hypertension: Renal Denervation: Hype After Initial Hope/Lessons to be Learned From its Fall/Other Methods Influencing the Autonomic Nervous System

Year: 2014

Type: article

Abstract: The unexpected announcement of Symplicity HTN-3 trial by the sponsor company that renal sympathetic denervation (RDN) failed to meet its primary efficacy end-point at 6 months raised concerns regarding the extent of blood pressure (BP) lowering results of the procedure.1 But the answer to the “burning” question of whether we should stop research and clinical implementation of RDN based on the results of one trial needs a cautious approach.

Source: Hospital chronicles/Hospital Chronicles

Authors: Costas Tsioufis, Kyriakos Dimitriadis, Christodoulos Stefanadis

Institutions: National and Kapodistrian University of Athens, Hippocration General Hospital

Language: English

Topic: Blood Pressure and Hypertension Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W1540783331

FWCI:

Cites: 33

Cited by:

Related to: 10